Cited by 1,513Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Mullan, Mike, Crawford, Fiona, Axelman, Karin, Houlden, Henry, Lilius, Lena, Winblad, Bengt, Lannfelt, Lars·1992·Nature Genetics

DOI 10.1038/ng0892-345

Open this paper in CoChat — free account

Abstract

Mutations at codon 717 in exon 17 of the beta-amyloid precursor protein (APP) gene have previously been shown to segregate with early onset Alzheimer's disease in some families. We have identified a double mutation at codons 670 and 671 (APP 770 transcript) in exon 16 which co-segregates with the disease in two large (probably related) early-onset Alzheimer's disease families from Sweden. Two base pair transversions (G to T, A to C) from the normal sequence predict Lys to Asn and Met to Leu amino acid substitutions at codons 670 and 671 of the APP transcript. This mutation occurs at the amino terminal of beta-amyloid and may be pathogenic because it occurs at or close to the endosomal/lysosomal cleavage site of the molecule. Thus, pathogenic mutations in APP frame the beta-amyloid sequence.

Integrity signals

Registry

Crossref · 10.1038/ng0892-345

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citation
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I. M., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,399
Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
Self-citation
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J. R., Farlow, M. R., Ghetti, B. F., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,142

Flagged first, then by citations

Show all 22 references

Research works printed but not linked: 2

Hardy, J. et al. Lancet 337, 1342–1343 (1991).
Weeks, D.E., Ott, J. & Lathrop, G M. Am. J. hum. Genet. 47(3), A204 (1990).

Sorted by citations

Items 601–700 of 1,002

Effects of Oxidative Stress on the Solubility of HRD1, a Ubiquitin Ligase Implicated in Alzheimer’s Disease
Saito, R., Kaneko, M., Kitamura, Y., Takata, K., Kawada, K., Okuma, Y., & Nomura, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094576 · Cited by 39
Intact blood-brain barrier transport of small molecular drugs in animal models of amyloid beta and alpha-synuclein pathology
Gustafsson, S. S., Lindström, V., Ingelsson, M., Hammarlund‐Udenaes, M., & Syvänen, S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.002 · Cited by 39
Cellular Cofactors for Amyloid β-Peptide-Induced Cell Stress
Yan, S. D., Roher, A. E., Schmidt, A. M., & Stern, D. M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65452-1 · Cited by 40
Treatment of Alzheimer’s Disease: Current Approaches and Promising Developments
Small, G. W. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00027-8 · Cited by 41
No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the β-cleaved C-terminal APP fragment
Rutten, B. P. F., Wirths, O., van de Berg, W. D. J., Lichtenthaler, S. F., Vehoff, J., Steinbusch, H. W. M., Korr, H., Beyreuther, K. T., Multhaup, G., Bayer, T. A., et al. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00015-3 · Cited by 39
Altered Amyloid-β Metabolism and Deposition in Genomic-based β-Secretase Transgenic Mice
Chiocco, M. J., Kulnane, L. S., Younkin, L. H., Younkin, S., Evin, G. M., & Lamb, B. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409680200 · Cited by 39
APP processing, Aβ-amyloidogenesis, and the pathogenesis of Alzheimer's disease
Gandy, S., Caporaso, G. L., Buxbaum, J. D., Frangione, B., & Greengard, P. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90125-2 · Cited by 39
Amyloid precursor protein‐processing products affect mononuclear phagocyte activation: pathways for sAPP‐ and Aβ‐mediated neurotoxicity
Ikezu, T., Luo, X., Weber, G. A., Zhao, J., McCabe, L., Buescher, J. L., Ghorpade, A., Zheng, J., & Xiong, H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01739.x · Cited by 39
Amyloid precursor protein truncated at any of the ?-secretase sites is not cleaved to ?-amyloid
Paganetti, P., Lis, M., Klafki, H.-W., & Staufenbiel, M. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19961101)46:3 · Cited by 39
Navigating the intersection: Diabetes and Alzheimer's intertwined relationship
Kale, M. B., Bhondge, H. M., Wankhede, N. L., Shende, P. V., Thanekar, R., Aglawe, M. M., Rahangdale, S. R., Taksande, B. G., Pandit, S. B., Upaganlawar, A. B., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102415 · Cited by 38
Genetic Inhibition of Phosphorylation of the Translation Initiation Factor eIF2α Does Not Block Aβ-Dependent Elevation of BACE1 and APP Levels or Reduce Amyloid Pathology in a Mouse Model of Alzheimer’s Disease
Sadleir, K. R., Eimer, W. A., Kaufman, R. J., Osten, P., & Vassar, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101643 · Cited by 40
Transgenic animal models of neurodegeneration based on human genetic studies
Harvey, B. K., Richie, C. T., Hoffer, B. J., & Airavaara, M. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0476-6 · Cited by 38
A Novel Transgenic Rat Model of Robust Cerebral Microvascular Amyloid with Prominent Vasculopathy
Davis, J., Xu, F., Hatfield, J. T., Lee, H., Hoos, M. D., Popescu, D. L., Crooks, E. J., Kim, R., Smith, S. O., Robinson, J. K., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.07.030 · Cited by 39
Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis
Benosman, S., Groß, I., Clarke, N., Jochemsen, A. G., Okamoto, K., Loeffler, J., & Gaiddon, C. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402216 · Cited by 38
Early Endosomal Abnormalities and Cholinergic Neuron Degeneration in Amyloid-β Protein Precursor Transgenic Mice
Choi, J. H. K., Kaur, G., Mazzella, M. J., Morales‐Corraliza, J., Levy, E., & Mathews, P. M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122143 · Cited by 41
Chronic Amyloid β Oligomer Infusion Evokes Sustained Inflammation and Microglial Changes in the Rat Hippocampus via NLRP3
Fekete, C., Vastagh, C., Dénes, Á., Hrabovszky, E., Nyíri, G., Kalló, I., Liposits, Z., & Sárvári, M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.046 · Cited by 39
Carboxyl-terminal fragments of beta-amyloid precursor protein bind to microtubules and the associated protein tau.
Islam, K., & Levy, E. (1997) · Europe PMC (PubMed Central) · Cited by 40
Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians
Morris, C. M., Benjamin, R., Leake, A., McArthur, F. K., Candy, J. M., Ince, P. G., Torvik, A., Bjertness, E., & Edwardson, J. A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)12126-b · Cited by 38
What transgenic mice tell us about neurodegenerative disease
Gurney, M. E. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200003)22:3 · Cited by 38
Monogenetic determinants of Alzheimer's disease: APP mutations
Goate, A. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050218 · Cited by 41
Infliximab ameliorates AD-associated object recognition memory impairment
Kim, D. H., Choi, S., Jho, J., Park, M., Kang, J., Park, S. J., Ryu, J. H., Jo, J., Kim, H. H., & Kim, B. C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.001 · Cited by 37
Mind the Gap: Mitochondria and the Endoplasmic Reticulum in Neurodegenerative Diseases
Leal, N. S., & Martins, L. M. (2021) · Biomedicines · doi:10.3390/biomedicines9020227 · Cited by 40
The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions
Keller, L., Welander, H., Chiang, H., Tjernberg, L. O., Nennesmo, I., Wallin, Å. K., & Graff, C. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.107 · Cited by 40
Examination of the role of endopeptidase 3.4.24.15 in Aβ secretion by human transfected cells
Chevallier, N., Jiráček, J., Vincent, B., Baur, C.-P., Spillantini, M. G., Goedert, M., Dive, V., & Checler, F. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701151 · Cited by 37
Functional Overexpression of γ-Secretase Reveals Protease-independent Trafficking Functions and a Critical Role of Lipids for Protease Activity
Wrigley, J. D. J., Schurov, I., Nunn, E. J., Martin, A. C. L., Clarke, E. E., Ellis, S., Bonnert, T. P., Shearman, M. S., & Beher, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413086200 · Cited by 37
Cholesterol-Like Effects of Selective Cyclooxygenase Inhibitors and Fibrates on Cellular Membranes and Amyloid-β Production
Gamerdinger, M., Clement, A. B., & Behl, C. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.034009 · Cited by 37
Molecular Neurobiology of Alzheimer's Disease (Syndrome?)
Zubenko, G. S. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709000303 · Cited by 37
Epidemiologic and Genetic Studies of Dementia of the Alzheimer Type in Japan
Urakami, K., Adachi, Y., Wakutani, Y., Isoe, K., Ji, Y., Takahashi, K., & Nakashima, K. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017074 · Cited by 37
Molecular pathology of Alzheimer's disease.
Rossor, M. N. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.6.583 · Cited by 37
Biochemistry of Alzheimer's disease amyloid plaques
Fraser, P. E., Lévesque, L., & McLachlan, D. R. C. (1993) · Clinical Biochemistry · doi:10.1016/0009-9120(93)90110-r · Cited by 38
The Amyloid Cascade Hypothesis
Castellani, R. J., Jamshidi, P., Plascencia‐Villa, G., & Perry, G. L. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.10.014 · Cited by 39
The vexing complexity of the amyloidogenic pathway
Castro, M., Hadziselimovic, A., & Sanders, C. R. (2019) · Protein Science · doi:10.1002/pro.3606 · Cited by 40
Longitudinal assessment of the neuroanatomical consequences of deep brain stimulation: Application of fornical DBS in an Alzheimer’s mouse model
Gallino, D., Devenyi, G. A., Germann, J., Guma, E., Anastassiadis, C., & Chakravarty, M. M. (2019) · Brain Research · doi:10.1016/j.brainres.2019.03.030 · Cited by 38
Pathogenic Effects of Cerebral Amyloid Angiopathy Mutations in the Amyloid β‐Protein Precursor
Nostrand, W. E. V., Melchor, J. P., Romanov, G. A., Zeigler, K., & Davis, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04824.x · Cited by 36
APP induces neuronal apoptosis through APP-BP1-mediated downregulation of β-catenin
Chen, Y. Z. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000031447.05354.9f · Cited by 36
Biochemical and immunocytochemical characterization of calsenilin in mouse brain
Zaidi, N. F., Berezovska, O., Choi, E., Miller, J. S., Chan, H., Lilliehöök, C., Hyman, B. T., Buxbaum, J. D., & Wasco, W. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00251-8 · Cited by 36
The Functions of the Amyloid Precursor Protein Gene
Panegyres, P. K. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.1.1 · Cited by 36
A novel pathogenic mutation (Leu262Phe) found in the presenilin 1 gene in early-onset Alzheimer's disease
Forsell, C., Froelich, S., Axelman, K., Vestling, M., Cowburn, R. F., Lilius, L., Johnston, J. A., Engvall, B., Johansson, K., Dahlkild, Å., et al. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00603-4 · Cited by 36
Self-citation
Proteolytical processing of mutated human amyloid precursor protein in transgenic mice
Czech, C., Delaère, P., Macq, A. F., Reibaud, M., Dreisler, S., Touchet, N., Schombert, B., Mazadier, M., Mercken, L., Theisen, M., et al. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00039-9 · Cited by 36
Confirmation of association between D10S583 and Alzheimer's disease in a case–control sample
Ait‐Ghezala, G., Abdullah, L. I., Crescentini, R. M., Crawford, F., Town, T., Singh, S., Richards, D., Duara, R., & MULLAN, M. J. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00243-4 · Cited by 36
Self-citation
Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer’s Disease
Gelman, S., Palma, J. D., Tombaugh, G. C., & Ghavami, A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170457 · Cited by 36
Neurophysiological assessment of neural network plasticity and connectivity: Progress towards early functional biomarkers for disease interception therapies in Alzheimer’s disease
Walsh, C., Drinkenburg, W. H. I. M., & Ahnaou, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.020 · Cited by 37
Apolipoprotein E deposition and astrogliosis are associated with maturation of β-amyloid plaques in βAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer’s disease
Terai, K., Iwai, A., Kawabata, S., Sasamata, M., Miyata, K., & Yamaguchi, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02202-8 · Cited by 36
Hypocapnia Induces Caspase-3 Activation and Increases Aβ Production
Xie, Z., Moir, R. D., Romano, D., Tesco, G., Kovacs, D. M., & Tanzi, R. E. (2004) · Neurodegenerative Diseases · doi:10.1159/000076667 · Cited by 35
Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease
Hardy, J. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320600519 · Cited by 35
The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease
Chen, X., Xia, Y., Alford, M. F., DeTeresa, R. M., Hansen, L. A., Klauber, M. R., Katzman, R., Thal, L. J., Masliah, E., & Saitoh, T. (1995) · Annals of Neurology · doi:10.1002/ana.410380415 · Cited by 35
White matter changes in familial Alzheimer's disease
Li, X., Westman, E., Ståhlbom, A. K., Thordardottir, S., Almkvist, O., Blennow, K., Wahlund, L., & Graff, C. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12352 · Cited by 35
Genetic Variants and Oxidative Stress in Alzheimer’s Disease
Kowalska, M., Wize, K., Prendecki, M., Lianeri, M., Kozubski, W. P., & Dorszewska, J. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200224121447 · Cited by 34
The assembly of the Mitochondrial Complex I Assembly complex uncovers a redox pathway coordination
McGregor, L., Acajjaoui, S., Desfosses, A., Saïdi, M., Bacia‐Verloop, M., Schwarz, J., Juyoux, P., von Velsen, J., Bowler, M. W., McCarthy, A. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43865-0 · Cited by 36
Characterization of Recombinant, Soluble β-Secretase from an Insect Cell Expression System
Mallender, W. D., Yager, D., Onstead, L., Nichols, M. R., Eckman, C. B., Sambamurti, K., Kopcho, L. M., Marcinkeviciene, J. A., Copeland, R. A., & Rosenberry, T. L. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12254-7 · Cited by 34
Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease
Blom, E. S., Viswanathan, J., Kilander, L., Helisalmi, S., Soininen, H. S., Lannfelt, L., Ingelsson, M., Glaser, A., & Hiltunen, M. O. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201966 · Cited by 35
Self-citation
Production of Amyloid β Protein from Normal Amyloid β‐Protein Precursor (βAPP) and the Mutated βAPPS Linked to Familial Alzheimer's Diseasea
Golde, T. E., Cai, X.-D., Shoji, M., & Younkin, S. G. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23036.x · Cited by 35
Synaptic transmission and synchronous activity is disrupted in hippocampal slices taken from aged TAS10 mice
Brown, J. T., Richardson, J. C., Collingridge, G. L., Randall, A. D., & Davies, C. H. (2004) · Hippocampus · doi:10.1002/hipo.20036 · Cited by 34
Clinical and Neuroimaging Features of Familial Alzheimer's Diseasea
Rossor, M. N., Kennedy, A. M., & Frackowiak, R. S. J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34400.x · Cited by 34
Diagnosis of Alzheimer's Disease
Reisberg, ‌., Burns, A. S., Brodaty, H., Eastwood, R., Rossor, M. N., Sartorius, N., & Winblad, B. G. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004675 · Cited by 36
Self-citation
CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects
Khan, M. S., Qureshi, N., Khan, R., Son, Y., & Maqbool, T. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1578138 · Cited by 37
Real-time nanoscale organization of amyloid precursor protein
Kedia, S., Ramakrishna, P., Netrakanti, P. R., Jose, M., Sibarita, J., Nadkarni, S., & Nair, D. K. (2020) · Nanoscale · doi:10.1039/d0nr00052c · Cited by 33
Mutation screening of patients with Alzheimer disease identifies APP locus duplication in a Swedish patient
Thonberg, H., Fallström, M., Björkström, J., Schoumans, J., Nennesmo, I., & Graff, C. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-476 · Cited by 35
Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity
Johansson, P., Kaspersson, K., Gurrell, I. K., Bäck, E., Eketjäll, S., Scott, C. W., Cebers, G., Thorne, P. V., McKenzie, M. J., Beaton, H. G., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01716 · Cited by 33
Neuro-protective effects of aloperine in an Alzheimer’s disease cellular model
Zhao, J., Zhang, G., Li, M., Luo, Q., Leng, Y., & Liu, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.008 · Cited by 33
The Amyloid Peptide and Its Precursor in Alzheimer's Disease
Octave, J. N. (1995) · Reviews in the Neurosciences · doi:10.1515/revneuro.1995.6.4.287 · Cited by 34
Genetic counseling in a Swedish Alzheimer family with amyloid precursor protein mutation.
Lannfelt, L., Axelman, K., Lilius, L., & Basun, H. (1995) · Europe PMC (PubMed Central) · Cited by 33
Self-citation
A Follow-Up Study of the Family with the Swedish APP 670/671 Alzheimer’s Disease Mutation
Wahlund, L., Basun, H., Almkvist, O., Julin, P., Axelman, K., Shigeta, M., Jelić, V., Nordberg, A. K., & Lannfelt, L. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017200 · Cited by 33
Self-citation
Pharmacological treatment of cognitive dysfunction in dementia disorders
Nordberg, A. K. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb00379.x · Cited by 33
Secretases as therapeutic targets for the treatment of Alzheimer's disease
Dominguez, D. I., Strooper, B. D., & Annaert, W. G. (2001) · Amyloid · doi:10.3109/13506120109007356 · Cited by 35
Somatostatin-evoked Aβ catabolism in the brain: Mechanistic involvement of α-endosulfine-KATP channel pathway
Watamura, N., Kakiya, N., Nilsson, P., Tsubuki, S., Kamano, N., Takahashi, M., Hashimoto, S., Sasaguri, H., Saito, T., & Saido, T. C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01368-8 · Cited by 32
The Role of Heme and Copper in Alzheimer’s Disease and Type 2 Diabetes Mellitus
Pal, I., & Dey, S. G. (2023) · JACS Au · doi:10.1021/jacsau.2c00572 · Cited by 32
Genetic and biochemical markers for Alzheimer's disease: recent developments
Mulder, C., Scheltens, P., Visser, J. J., van Kamp, G. J., & Schutgens, R. B. H. (2000) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563001899898 · Cited by 32
Alzheimer?s disease?a sum greater than its parts?
Adlard, P. A., & Cummings, B. J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.016 · Cited by 32
Familial Alzheimer disease associated with A713T mutation in APP
Armstrong, J., Boada, M., Rey, M. J., Vidal, N., & Ferrer, I. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.08.026 · Cited by 34
Genetic Analyses of Alzheimer’s Disease in China: Achievements and Perspectives
Zhang, D., Xu, M., Bi, R., & Yao, Y. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00435 · Cited by 32
Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): A review of the variety in phenotypic expression
Bornebroek, M., Haan, J., & Roos, R. A. C. (1999) · Amyloid · doi:10.3109/13506129909007331 · Cited by 32
Genetic heterogeneity of gene defects responsible for familial Alzheimer disease
Tanzi, R. E., Gaston, S. M., Bush, A. I., Romano, D., Pettingell, W. H., Peppercorn, J. M., Paradis, M. D., Gurubhagavatula, S., Jenkins, B., & Wasco, W. (1993) · Genetica · doi:10.1007/bf01436002 · Cited by 32
Cultured cell and transgenic mouse models for tau pathology linked to β-amyloid
Bloom, G. S., Ren, K., & Glabe, C. G. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.008 · Cited by 32
The heat shock/oxidative stress connection
Pappolla, M. A., Sos, M., Omar, R. A., & Sambamurti, K. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815201 · Cited by 32
Dietary intervention with edible medicinal plants and derived products for prevention of Alzheimer's disease: A compendium of time-tested strategy
Peng, Y., Tao, H., Wang, S., Xiao, J., Wang, Y., & Su, H. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104463 · Cited by 31
Cathepsin D: Analysis of its potential role as an amyloid beta degrading protease
Gallwitz, L., Schmidt, L., Marques, A. R. A., Tholey, A., Cassidy, L., Ulku, I., Multhaup, G., Spiezio, A. D., & Säftig, P. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105919 · Cited by 34
The Role of Methylated Circulating Nucleic Acids as a Potential Biomarker in Alzheimer’s Disease
Pai, M., Kuo, Y., Wang, I., Chiang, P., & Tsai, K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1229-z · Cited by 31
Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020)
Rombouts, F. J. R., Kusakabe, K., Hsiao, C., & Gijsen, H. J. M. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1832463 · Cited by 31
Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer’s disease
Kloskowska, E., Pham, T. M., Nilsson, T., Zhu, S., Öberg, J., Codita, A., Pedersen, L. Ø., Pedersen, J. T., Małkiewicz, K., Winblad, B. G., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00809.x · Cited by 31
Self-citation
What Can Rodent Models Tell Us About Cognitive Decline in Alzheimer's Disease?
Davis, S., & Laroche, S. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:3:249 · Cited by 32
Innate immunity in Alzheimer’s disease: the relevance of animal models?
Franco-Bocanegra, D., Nicoll, J. A. R., & Boche, D. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1729-4 · Cited by 32
Cleavage of full-length βAPP mRNA by hammerhead ribozymes
Denman, R. B. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.17.4119 · Cited by 31
Overexpression of Human Amyloid Precursor Protein in Drosophila
Yagi, Y., Tomita, S., Nakamura, M., & Suzuki, T. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0248 · Cited by 31
The molecular genetics of Alzheimer's disease
MULLAN, M. J., & Crawford, F. (1994) · Molecular Neurobiology · doi:10.1007/bf02816100 · Cited by 32
Self-citation
Immunohistochemical analysis of COOH-termini of amyloid beta protein (Aβ) using end-specific antisera for Aβ40 and Aβ42 in Alzheimer's disease and normal aging
Yamaguchi, H., Sugihara, S., Ishiguro, K., Takashima, A., & Hirai, S. (1995) · Amyloid · doi:10.3109/13506129509031882 · Cited by 31
Nucleotide sequence of the chromosome 14-encodedS182cDNA and revised secondary structure prediction
Slunt, H. H., Thinakaran, G., Lee, M. K., & Sisodia, S. S. (1995) · Amyloid · doi:10.3109/13506129509036925 · Cited by 31
Translating Alzheimer’s disease-associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs
Katsumata, Y., Nelson, P. T., Estus, S., & Fardo, D. W. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.017 · Cited by 30
A simple and label-free electrochemical method for detection of beta-site amyloid precursor protein cleaving enzyme and screening of its inhibitor
Xia, N., Zhang, Y.-J., Guan, P., Hao, Y., & Liu, L. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.02.081 · Cited by 30
The integration site of the APP transgene in the J20 mouse model of Alzheimer’s disease
Tosh, J., Rickman, M., Rhymes, E., Norona, F. E., Clayton, E. L., Mucke, L., Isaacs, A. M., Fisher, E., & Wiseman, F. K. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.12237.2 · Cited by 30
Alzheimer's disease amyloid-β pathology in the lens of the eye
Moncaster, J. A., Moir, R. D., Burton, M. A., Chadwick, O., Minaeva, O. V., Alvarez, V. E., Ericsson, M., Clark, J. I., McKee, A. C., Tanzi, R. E., et al. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.108974 · Cited by 30
What is ‘early onset dementia’?
Miyoshi, K. (2009) · Psychogeriatrics · doi:10.1111/j.1479-8301.2009.00274.x · Cited by 36
Mutational spectral analysis at the HPRT locus in healthy children
Finette, B. A., Kendall, H. E., & Vacek, P. M. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00119-7 · Cited by 30
Alzheimer's Disease, ß-Amyloidosis, and Aging
Coria, F., Rubio, I., & Bayón, C. (1994) · Reviews in the Neurosciences · doi:10.1515/revneuro.1994.5.4.275 · Cited by 34
In search of the soluble
Hardy, J., & Mullan, M. (1992) · Nature · doi:10.1038/359268a0 · Cited by 31
Self-citation
Cellular and molecular basis of beta-amyloid precursor protein metabolism
Xu, H. (1998) · Frontiers in bioscience · doi:10.2741/a283 · Cited by 30
Genetic Variation in N-Methyl-D-Aspartate Receptor Subunit NR3A but Not NR3B Influences Susceptibility to Alzheimer’s Disease
Liu, H.-P., Lin, W.-Y., Liu, S.-H., Wang, W.-F., Tsai, C.-H., Wu, B.-T., Wang, C.-K., & Tsai, F.-J. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000254757 · Cited by 29
Increased glucose metabolism and impaired glutamate transport in human astrocytes are potential early triggers of abnormal extracellular glutamate accumulation in hiPSC ‐derived models of Alzheimer's disease
Salcedo, C., Garcia, V. P., García‐Adán, B., Ameen, A. O., Gegelashvili, G., Waagepetersen, H. S., Freude, K., & Aldana, B. I. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16014 · Cited by 30
Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts
Kawakubo, T., Mori, R., Shirotani, K., Iwata, N., & Asai, M. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00825 · Cited by 29
Presenilins and the γ-secretase: still a complex problem
Small, D. H., Klaver, D. W., & Foa, L. C. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-7 · Cited by 29

Authors: Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L.
Affiliations: University of South Florida (US)
Karolinska Institutet (SE)
St Mary's Hospital (GB)
ORCID: Crawford, Fiona
Houlden, Henry
Winblad, Bengt
Lannfelt, Lars
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 1992-08
Volume: 1
Issue: 5
Pages: 345-347
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng0892-345
OpenAlex: W2030641075
Cited by: 1,513
References: 22
Citations by year: 2026: 24 · 2025: 30 · 2024: 50 · 2023: 47 · 2022: 49 · 2021: 46 · 2020: 52 · 2019: 56 · 2018: 48 · 2017: 48 · 2016: 47 · 2015: 31 · 2014: 62 · 2013: 31 · 2012: 32
FWCI: 49.77
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: Alzheimer's disease, APP gene, amyloid-beta, early-onset familial Alzheimer's disease, Swedish families
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Base Sequence, Brain, Codon, Exons, Female, Humans, Genetic Linkage, Male, Middle Aged, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Transcription, Genetic, Genetic Variation, Amyloid beta-Protein Precursor, Point Mutation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks